AZD3676
AZD3676 is an orally active and blood-brain barrier-permeable ligand for 5-HT1ₐ and 5-HT1ᵦ receptors, with nanomolar binding affinity. AZD3676 is applicable to research related to cognitive impairment in Alzheimer's disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1259929-13-9
- Formule: C22H26N4O2
- Masse moléculaire:378.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform 5-HT Receptor
More
Activité biologique
|
5-HT1A Receptor |
5-HT1B/D Receptor |
AZD3676 (16 h) exhibits nanomolar affinity for 5-HT1A (Ki = 0.13 nM) and 5-HT1B (Ki = 2.4 nM) receptors in cynomolgus monkey brain homogenates[1].
AZD3676 (0.4-20 μM) shows concentration-dependent plasma protein binding, with species-specific unbound fractions ranging from 0.014 (human) to 0.37 (guinea pig) at the predicted therapeutic maximum concentration of ~1 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | CLplasma | Vdss | AUC0-inf | Cmax | T1/2 | Bioavailability |
|---|---|---|---|---|---|---|---|---|
| Rat[1] | 1 mg/kg | i.v. | 83 mL/min/kg | 5.2 L/kg | / | / | / | / |
| Rat[1] | 1 mg/kg | i.v. | 83 mL/min/kg | 5.2 L/kg | / | / | / | / |
| Rat[1] | 3 mg/kg | p.o. | / | / | 0.3 μM·h | 0.40 μM | 0.7 h | 21 % |
| Rat[1] | 3 mg/kg | p.o. | / | / | 0.3 μM·h | 0.40 μM | 0.7 h | 21 % |
| Dog[1] | 1 mg/kg | i.v. | 37 mL/min/kg | 3.5 L/kg | / | / | / | / |
| Dog[1] | 1 mg/kg | i.v. | 37 mL/min/kg | 3.5 L/kg | / | / | / | / |
| Dog[1] | 3 mg/kg | p.o. | / | / | 1.3 μM·h | 2.6 μM | 2.8 h | / |
| Dog[1] | 3 mg/kg | p.o. | / | / | 1.3 μM·h | 2.6 μM | 2.8 h | / |
AZD3676 (1-10 μmol/kg; s.c., p.o.; single dose) significantly reverses Scopolamine(HY-N0296)-induced cognitive impairment in C57BL/6 mice, as demonstrated by restored freezing behavior in a contextual fear conditioning assay[1].
AZD3676 (0.03-3 μmol/kg; s.c.; single dose) dose-dependently occupies 5-HT1ₐ receptors in healthy C57BL/6 mice, with a half-maximum receptor occupancy of 0.05 μmol/kg s.c. in the frontal cortex[1].
AZD3676 (0.1-10 μmol/kg; s.c.; single dose) dose-dependently occupies 5-HT1A receptors in healthy Sprague Dawley rats, with a half-maximum receptor occupancy of 0.17 μmol/kg s.c. in the frontal cortex[1].
AZD3676 (0.3-10 μmol/kg; s.c.; single dose) dose-dependently occupies 5-HT1A and 5-HT1B receptors in healthy Dunkin Hartley guinea pigs, with half-maximum receptor occupancy values of 0.3 μmol/kg s.c. and 1.2 μmol/kg s.c., respectively[1].
AZD3676 (0.16-0.82 μmol/kg; i.v.; maintenance infusion following initial low-dose bolus) dose-dependently occupies 5-HT1A receptors in healthy cynomolgus monkeys, with a Ki,plasma of 84 nM for half-maximum occupancy in the prefrontal cortex[1].
AZD3676 (0.1-1.8 μmol/kg; i.v.; maintenance infusion following initial low-dose bolus) dose-dependently occupies 5-HT1B receptors in healthy cynomolgus monkeys, with a Ki,plasma of 72 nM for half-maximum occupancy in the occipital cortex[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6[1]
-
Dosage:10 μmol/kg
-
Administration:s.c.; single dose
-
Result:Significantly reverted the R-8-OH-DPAT-induced memory deficit, as measured by increased freezing behavior relative to R-8-OH-DPAT-only treated mice.
-
Animal Model:C57BL/6[1]
-
Dosage:3 μmol/kg; 10 μmol/kg; 1 μmol/kg
-
Administration:s.c.; single dose; p.o.; single dose
-
Result:Significantly reverted the scopolamine-induced memory deficit at 3 μmol/kg s.c., 10 μmol/kg s.c., and 1 μmol/kg p.o., as measured by increased freezing behavior relative to scopolamine-only treated mice.
-
Animal Model:C57BL/6[1]
-
Dosage:0.03 μmol/kg; 0.1 μmol/kg; 0.3 μmol/kg; 1 μmol/kg; 3 μmol/kg
-
Administration:s.c.; single dose
-
Result:Dose-dependently occupied 5-HT1ₐ receptors in the mouse frontal cortex, with a half-maximum receptor occupancy of 0.05 μmol/kg s.c.
-
Animal Model:Sprague Dawley[1]
-
Dosage:0.1 μmol/kg; 1 μmol/kg; 3 μmol/kg; 10 μmol/kg
-
Administration:s.c.; single dose
-
Result:Dose-dependently occupied 5-HT1ₐ receptors in the rat frontal cortex, with aa half-maximum receptor occupancy of 0.17 μmol/kg s.c.
Chemical Information
-
CAS No. 1259929-13-9
-
Masse moléculaire 378.48
-
Formule C22H26N4O2
-
SMILES
O=C(C=1OC2=C(C=CC=C2N3CCN(CCC4=NC=CC=C4)CC3)C1)N(C)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz